États-Unis · Plateformes & données · MarketBeat
Arrowhead Pharmaceuticals, Inc. (ARWR) - What Are Researchers Thinking About This Stock?

Résumé détaillé
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR - Get Free Report) has been given a consensus rating of "Moderate Buy" by the fifteen analysts that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, three have given a hold rating, ten hav
MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)



